ArticleCancer medicine2018

Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

Meixian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.